Viral Vectored Vaccines against Influenza

Add to your list(s) Download to your calendar using vCal

• Dr Teresa Lambe; The Jenner Institute, University of Oxford
• Wednesday 18 July 2018, 12:00-13:00
• Babraham - The Cambridge Building; Kings Hedges Room.

If you have a question about this talk, please contact Bobbie Claxton.

If you would like to attend this seminar, please contact us to arrange site access

Vaccines are efficacious and cost-effective preventative healthcare measures and a global mainstay in protecting millions from infectious disease. Dr. Lambe’s research interest lies in the development of efficacious vaccines, principally toward influenza and emerging pathogens. Viral vectors have become a vaccine platform of choice for many pathogens that have evaded conventional vaccination approaches. Dr Lambe will discuss the broad applicability of viral vectors as a platform technology with a focus on their use for the prevention of influenza-mediated disease.

This talk is part of the Babraham Seminar series.

This talk is included in these lists:

• Babraham - The Cambridge Building; Kings Hedges Room
• Babraham Seminar
• Graduate-Seminars
• se393's list

Note that ex-directory lists are not shown.